www.rx-legal.com

Your reliable supplier of generic medications.

Check yourbonu$
Site search:
Obvious advantage Tell a friend and get discount! Want to give it a try?
Categories list

Generic Bicalutamide - Casodex

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Casodex

Generic Casodex

Bicalutamide 50mg

Generic Casodex is used for treating prostate cancer.This medicine is intended for use with other medicines.
More info »

$4.65 Buy now!
Choose Your language:
Social bookmarks:
Testimonials

I already received my parcel, I had a problem as the courier wanted to deliver to my home as they claim they cannot place the order into my postbox. This was my preferred option.
There is not someone at home always, so we had to get the parcel to my office. No problem with that.
I did have an enquiry into the 4 extra pills, and this was delivered within a few days via airmail to my post box.
I would suggest you attend to this part of your process as the extra cost is unnecessary. Include everything into one parcel.
All in all, good service. - Jan

Our billing is certified by:

Secure shopping certificates


Special Offer!

News

  • New Therapies for Prostate Cancer: The Practicalities - OncLive

    OncLiveNew Therapies for Prostate Cancer: The PracticalitiesOncLive12,13 This investigational agent is an irreversible androgen receptor (AR) antagonist and AR signaling inhibitor, and represents an advance from the nonsteroidal AR antagonists flutamide, bicalutamide, and nilutamide.

  • Medivation Reports First Quarter Financial Results and Provides Corporate Update - MarketWatch (press release)

    Medivation Reports First Quarter Financial Results and Provides Corporate UpdateMarketWatch (press release)Continued to enroll patients in the Phase 2 TERRAIN trial, which is comparing the effect of enzalutamide versus bicalutamide, the most commonly used anti-androgen, on progression-free survival in approximately 370 men with advanced prostate cancer who .

  • MDVN Misses; Focus on Enzalutamide - Zacks.com

    MDVN Misses; Focus on EnzalutamideZacks.

  • MDVN Misses; Focus on Enzalutamide - Analyst Blog - NASDAQ

    MDVN Misses; Focus on Enzalutamide - Analyst BlogNASDAQEnzalutamide is also in a phase II study (TERRAIN), which will compare enzalutamide with bicalutamide, in advanced prostate cancer patients who have progressed following medical castration with LHRH analog therapy or surgical castration.

  • CEO Brennan to leave AstraZeneca as profits sink - Pharma Times

    CEO Brennan to leave AstraZeneca as profits sinkPharma TimesAs for oncology, Arimidex (anastrozole) fell 39% to $144 million, battered by patent expiries, while Casodex (bicalutamide) fell 17% to $113 million.

Trusted. Rx approved.